Pillar 2: BioRepository & Discovery
Harnessing the power of a big data analysis to drive new knowledge
Problem: Australia is a global leader in allergy research, but information and datasets remain fragmented and segregated, making it challenging for experts to consolidate knowledge and reach effective research outcomes.
Solution: The pillar has collaborated with allergy and digital health experts to design the NACE Allergy BioRepository (ALBI). The platform will drive discoveries that lead to better ways to alleviate the growing burden of allergies on the community.
"ALBI is a collaboration between allergy and digital health experts to fuel faster, smarter discoveries. The platform will securely consolidate and integrate allergy data and biospecimens from national NACE-led and endorsed allergy studies."
- Co-chair of the National Allergy Centre of Excellence Respiratory Allergy Stream.
- Head of the Queensland University of Technology Allergy Research Group.
NACE Allergy BioRepository
Using cutting-edge digital health technology, ALBI will securely consolidate and integrate allergy data and biospecimens. It will power researchers to uncover a clearer picture of allergic disease across Australia and help them answer urgent questions.
RADS Survey
A study on researcher knowledge, attitudes and practices about health research data sharing in allergy (RADS) to help inform data access for ALBI. Complete the survey before 5pm Thursday 31 July.
Metadata platform
In collaboration with Melbourne Children’s LifeCourse, the Pillar has developed an Allergy Studies Metadata Platform to improve discoverability of allergy studies available for secondary research.
The landscape of digital health approaches to allergy in Australia
Chapter | First online: 22 April 2025
By Professor Janet Davies.
In proud partnership with
